suPAR at Congresses & Conferences
The ViroGates team visits a variety of scientific and commercial congresses every year.For 2012 the following events are planned:
2012:
November 14-17, Dusseldorf, Germany
MEDICA - World Forum for Medicine (www.medica-tradefair.com)
Helle Fisker, VP Sales & Marketing, and Claus Berner, Senoir Consultant, will be present to discuss business opportunities.
November 07-09, Paris, France
Sepsis 2012 (www.sepsisforum.org/sepsisconferences)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
October 13-17, Lisbon, Portugal
25´th ESICM LIVES 2012 - Annual Congress of the European Society of Intensive Care Medicine (www.esicm.org)
Claus Berner, Senior Consultant, will be present to discuss business opportunities.
September 19-22, Budapest, Hungary
SepsEast 2012 - 1´st Central and Eastern European Sepsis Forum (www.sepseast.eu)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
June 27-30, Dublin, Ireland
14´th ICEM - International Conference on Emergency Medicine (www.icem2012.org)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
June 18-21, Boston, USA
2012 BIO International Convention (www.convention.bio.org)
Jørgen Thorball, Chairman of the Board, ViroGates, will be present to discuss business opportunities.
June 7-8, Paris, France
2´nd Paris International Conference on Intensive Care, SRLF (www.pic-srlf.fr)
"Understanding the 2012 Surviving Sepsis Campaign guidelines"
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
May 31 - June 1, Grenoble, France
EuroMedtech 2012 - 4´th Annual International Medtech Partnering Conference (www.ebdgroup.com/emt)
Jakob Knudsen, CEO, will give a corporate presentation of ViroGates.
May 29-30, Helsinki, Finland
Acute Kidney Injury and Sepsis Symposium (www.sny.fi/nefro)
Oral presentation by Dr. Jesper Eugen-Olsen, Principal Investigator, Copenhagen University Hospital, Hvidovre, Denmark on May 30, 10.00-10.20: "suPAR in critically ill patients with sepsis and AKI"
May 23, London, United Kingdom
Anglonordic Medtech Conference (www.anglonordicmedtech.com)
Jakob Knudsen, CEO, will give a corporate presentation of ViroGates.
April 26-27, Manchester, United Kingdom
9´th Annual Critical Care Symposium (www.critcaresymposium.co.uk)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
March 20-23, Brussels, Belgium
32´nd ISICEM - International Symposium on Intensive Care and Emergency Medicine (www.intensive.org)
Jakob Knudsen, CEO, wil be present to discuss business opportunities.
February 27-28, Copenhagen, Denmark
3´nd International suPAR Symposium (www.conferencemanager.dk/suPAR2012)
"Discussion of the features and potential usability of the suPAR protein as a biomarker"
Hosted by Copenhagen University Hospital, Hvidovre, Denmark and sponsored by ViroGates.
Jakob Knudsen, CEO, and Claus Berner, VP Sales & Marketing is looking forward to meeting you.
2011:
November 16-19, Dusseldorf, Germany
MEDICA - World Forum for Medicine (www.medica-tradefair.com)
Jakob Knudsen, CEO, and Claus Berner, VP Sales & Marketing, will be present at Medica to discuss business opportunities.
November 12-16, Antalya, Turkey
1st National Clinical Microbiology Congress
suPARnostic® presented by Hemakim Medical Products (www.hemakim.com.tr) at the congress – please visit the stand and get introduction to suPARnostic®.
November 2-4, Rome, Italy
National Congress of the Academy of Emergency Medicine and Care (AcEMC)
“Good clinical practice and scientific research in emergency medicine".
Presentation on Nov. 2, 11.35-12.35:
"Use of biomarker suPAR in the prognostic evaluation of sepsis".
Oral presentations by Dr. Jesper Eugen Olsen, Laboratory Research Director, Hvidovre Hospital, Denmark (suPAR - The future risk biomarker in sepsis), Ivo Casagranda (Preliminary results from the multicentric study) and Carlo Arfini (suPAR seen from a Lab Manager point of view).
October 26-28, Beijing, China
Sepsis 2011 (www.sepsisforum.org/sepsisconferences)
Jakob Knudsen, CEO, will be present at the conference to discuss business opportunities.
October 25-28, Munich, Germany
Medical Biodefense Conference 2011 (www.biodefense2011.org)
Claus Berner, VP Sales & Marketing will be present on Oct. 26 to discuss business opportunities.
October 1-5, Berlin, Germany
24´th ESICM LIVES 2011 - Annual Congress of the European Society of Intensive Care Medicine (www.esicm.org)
Oral presentation of abstract by Dr Katia Donadello, Erasme Hospital, Brussels, Belgium on Oct. 4 at 15.25-15.40 in Stockholm room:
"Clinical Value of suPAR, a new biomarker"See Presentation Abstract here.
Jakob Knudsen, CEO, and Henrik Tommerup, VP Business Development, will be present at the congress Oct. 3-4 to discuss business opportunities.
September 28-29, Vienna, Austria
9´th Planet xMAP Europe, 2011 (www.planetxmap.com)
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
July 24-28, Atlanta, Georgia, USA
2011 AACC Annual Meeting - American Association for Clinical Chemistry (www.aacc.org/events)
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
May 25-26, Sibiu, Romania
2011 RSLM - 18´th National Congress of Laboratory Medicine (www.srlmcongres.ro/EN)
Oral presentation by Ch. Cristina Hristodorescu, General Manager, Praxis Medica, on May 26:
"Diagnosing patient criticality: Patient prognosis with suPARnostic®"
May 7-10, Milan, Italy
21’st ECCMID - European Congress of Clinical Microbiology and Infectious Diseases (www.eccmid-icc2011.org)
Presentation of abstract "Predictive value of soluble urokinase plasminogen activator factor in ventilator-associated pneumonia and sepsis".
See Presentation Abstract here.
Henrik Tommerup, VP Business Development, ViroGates, will be present to discuss business opportunities.
April 28-29, Manchester, United Kingdom
8´th Annual Critical Care Symposium (www.critcaresymposium.co.uk)
Henrik Tommerup, VP Business Development, ViroGates, will be present.
April 6-9, Madrid, Spain
4’th International Congress on Prediabetes and the Metabolic Syndrome (www.kenes.com/prediabetes)
Oral presentation of abstract by Dr. Steen B. Haugaard, Hvidovre Hospital, Copenhagen, Denmark:
"The immunue marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men"
Henrik Tommerup, VP Business Development, ViroGates, will also be present at the congress.
March 22-25, Brussels, Belgium
31´st ISICEM - International Symposium on Intensive Care and Emergency Medicine (www.intensive.org)
Four oral presentations on suPAR will take place:
"The Value of suPAR" by Georgios Dimopoulos (Athens, Greece)
"suPAR in sepsis" by Katia Donadello (Erasme Hospital, Brussels, Belgium)
"suPAR"by Frank Tacke (University Hospital Aachen, Germany)
"Towards better stratification?" by Evangelos Giamarellos-Bourboulis (Attikon Hospital, Athens, Greece)
For more information please see 
suPAR at ISICEM
Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, will be present at the Symposium.
March 17, Geneva, Switzerland
Healthcare in Europe
(http://eu.economistconferences.com/event/european-healthcare-summit)
Transforming Europe´s healthcare systems - where should change happen?
Henrik Tommerup, VP Business Development, ViroGates, will be present.
March 7-8, Copenhagen, Denmark
2´nd International suPAR Symposium (www.conferencemanager.dk/suPAR2011)
"Discussion of the features and potential usability of the suPAR protein as a biomarker"
Hosted by Hvidovre University Hospital, Copenhagen, Denmark and sponsored by ViroGates. Henrik Tommerup, VP Business Development, Claus Berner, VP Sales & Marketing, and Louise Hebert, Product Manager, is looking forward to meeting you.
February 24-26, Porto, Portugal
16th International Symposium on infections in the critically ill patient
(www.infections-online.com)
Claus Berner, VP Sales & Marketing, ViroGates, will be present at the Symposium.
January 13-15, Krakow, Poland
Collegium Medicine Laboratory meeting
Two oral presentations about suPAR in session IN VITRO PROGNOSTIC by Prof. Kulpa and Prof. Paradowski.
Louise Hebert, Product Manager, ViroGates will also be present.
